Pauline Funchain

Pauline Funchain is an Associate Professor of Medicine (Oncology) at Stanford University, specializing in cutaneous oncology and immunotherapy. She practices at Stanford Health Care and holds administrative roles including Associate Director at the Stanford Cancer Institute and Co-Director of the Immunotherapy Toxicity Program.

• Education: MD from The Ohio State University, Fellowship at Cleveland Clinic, and Residency at Harbor UCLA.
• Research: Focuses on melanoma, germline predisposition, immune-related adverse events (irAEs), and precision oncology, with a particular interest in biomarkers and multi-omic profiling of early-stage tumors.
• Clinical Trials: Investigates neoadjuvant/adjuvant therapies for ocular and cutaneous melanoma, including ICI combinations and targeted therapies like TAS-117 and nemvaleukin.
• Leadership: Serves as Associate Program Director for Hematology and Oncology Fellowship at Stanford and leads initiatives in cancer research training.
• Publications: Her work spans immunotherapy efficacy, cardiovascular and neurological irAEs, and germline mutation impacts on melanoma survival, contributing to national guidelines on immune-related adverse event management.